{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T14:27:09Z","timestamp":1778164029561,"version":"3.51.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2006,11,29]],"date-time":"2006-11-29T00:00:00Z","timestamp":1164758400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Pharmacokinet Pharmacodyn"],"published-print":{"date-parts":[[2007,3,30]]},"DOI":"10.1007\/s10928-006-9040-2","type":"journal-article","created":{"date-parts":[[2006,11,28]],"date-time":"2006-11-28T18:52:01Z","timestamp":1164739921000},"page":"183-206","source":"Crossref","is-referenced-by-count":52,"title":["Population Pharmacokinetics of Risperidone and 9-Hydroxyrisperidone in Patients with Acute Episodes Associated with Bipolar I Disorder"],"prefix":"10.1007","volume":"34","author":[{"given":"An","family":"Vermeulen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir","family":"Piotrovsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth A.","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,11,29]]},"reference":[{"key":"9040_CR1","first-page":"494","volume":"41","author":"J.E. Leysen","year":"1992","unstructured":"Leysen J.E., Janssen P.M., Gommeren W., Wynants J., Pauwels P.J., Janssen P.A. (1992) In vitro and in vivo receptor binding and effects on monoamine turnover in rat brain regions of the novel antipsychotics risperidone and ocaperidone. Mol. Pharmacol. 41:494\u2013508","journal-title":"Mol. Pharmacol."},{"key":"9040_CR2","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1176\/appi.ajp.161.6.1057","volume":"161","author":"R.M. Hirschfeld","year":"2004","unstructured":"Hirschfeld R.M., Keck P.E., Jr., Kramer M., Karcher K., Canuso C., Eerdekens M., Grossman F. (2004) Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial. Am. J. Psychiatry 161:1057\u20131065","journal-title":"Am. J. Psychiatry"},{"key":"9040_CR3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.euroneuro.2004.06.003","volume":"15","author":"A.B. Smulevich","year":"2005","unstructured":"Smulevich A.B., Khanna S., Eerdekens M., Karcher K., Kramer M., Grossman F. (2005) Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol. Eur. Neuropsychopharmacol. 15:75\u201384","journal-title":"Eur. Neuropsychopharmacol."},{"key":"9040_CR4","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1176\/appi.ajp.159.7.1146","volume":"159","author":"G.S. Sachs","year":"2002","unstructured":"Sachs G.S., Grossman F., Ghaemi S.N., Okamoto A., Bowden C.L. (2002) Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety. Am. J. Psychiatry 159:1146\u20131154","journal-title":"Am. J. Psychiatry"},{"key":"9040_CR5","first-page":"141","volume":"182","author":"L.N. Yatham","year":"2003","unstructured":"Yatham L.N., Grossman F., Augustyns I., Vieta E., Ravindran A. (2003) Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial. Br. J. Psychiatry 182:141\u2013147","journal-title":"International, double-blind, randomised controlled trial. Br. J. Psychiatry"},{"key":"9040_CR6","doi-asserted-by":"crossref","first-page":"707","DOI":"10.4088\/JCP.v65n0518","volume":"65","author":"C.L. Bowden","year":"2004","unstructured":"Bowden C.L., Myers J.E., Grossman F., Xie Y. (2004) Risperidone in combination with mood stabilizers: a 10-week continuation phase study in bipolar I disorder. J. Clin. Psychiatry 65:707\u2013714","journal-title":"J. Clin. Psychiatry"},{"key":"9040_CR7","doi-asserted-by":"crossref","first-page":"818","DOI":"10.4088\/JCP.v62n1011","volume":"62","author":"E. Vieta","year":"2001","unstructured":"Vieta E., Goikolea J.M., Corbella B., Benabarre A., Reinares M., Martinez G., Fernandez A., Colom F., Martinez-Aran A., Torrent C. (2001) Risperidone safety and efficacy in the treatment of bipolar and schizoaffective disorders: results from a 6-month, multicenter, open study. J. Clin. Psychiatry 62:818\u2013825","journal-title":"J. Clin. Psychiatry"},{"key":"9040_CR8","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/00004850-200307000-00005","volume":"18","author":"L.N. Yatham","year":"2003","unstructured":"Yatham L.N., Binder C., Riccardelli R., Leblanc J., Connolly M., Kusumakar V. (2003) Risperidone in acute and continuation treatment of mania. Int. Clin. Psychopharmacol. 18:227\u2013235","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"Suppl May","key":"9040_CR9","first-page":"13","volume":"55","author":"J. Heykants","year":"1994","unstructured":"Heykants J., Huang M.L., Mannens G., Meuldermans W., Snoeck E., Van Beijsterveldt L., Van Peer A., Woestenborghs R. (1994) The pharmacokinetics of risperidone in humans: a summary. J. Clin. Psychiatry 55(Suppl May):13\u201317","journal-title":"J. Clin. Psychiatry"},{"key":"9040_CR10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00004714-199604000-00010","volume":"16","author":"M.J. Byerly","year":"1996","unstructured":"Byerly M.J., DeVane C.L. (1996) Pharmacokinetics of clozapine and risperidone: a review of recent literature. J. Clin. Psychopharmacol. 16:177\u2013187","journal-title":"J. Clin. Psychopharmacol."},{"key":"9040_CR11","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/clpt.1993.146","volume":"54","author":"M.L. Huang","year":"1993","unstructured":"Huang M.L., Van Peer A., Woestenborghs R., De Coster R., Heykants J., Jansen A.A., Zylicz Z., Visscher H.W., Jonkman J.H. (1993) Pharmacokinetics of the novel antipsychotic agent risperidone and the prolactin response in healthy subjects. Clin. Pharmacol. Ther. 54:257\u2013268","journal-title":"Clin. Pharmacol. Ther."},{"issue":"Suppl 11","key":"9040_CR12","first-page":"12","volume":"57","author":"L. Ereshefsky","year":"1996","unstructured":"Ereshefsky L. (1996) Pharmacokinetics and drug interactions: update for new antipsychotics. J. Clin. Psychiatry 57(Suppl 11):12\u201325","journal-title":"J. Clin. Psychiatry"},{"key":"9040_CR13","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/00007691-200008000-00019","volume":"22","author":"E. Spina","year":"2000","unstructured":"Spina E., Avenoso A., Facciola G., Salemi M., Scordo M.G., Giacobello T., Madia A.G., Perucca E. (2000) Plasma concentrations of risperidone and 9-hydroxyrisperidone: effect of comedication with carbamazepine or valproate. Ther. Drug Monit. 22:481\u2013485","journal-title":"Ther. Drug Monit."},{"key":"9040_CR14","first-page":"1263","volume":"29","author":"N. Yasui-Furukori","year":"2001","unstructured":"Yasui-Furukori N., Hidestrand M., Spina E., Facciola G., Scordo M.G., Tybring G. (2001) Different enantioselective 9-hydroxylation of risperidone by the two human CYP2D6 and CYP3A4 enzymes. Drug Metab. Dispos. 29:1263\u20131268","journal-title":"Drug Metab. Dispos."},{"key":"9040_CR15","unstructured":"A. Boeckman, L. Sheiner, and S. Beal. NONMEM Users Guides. University of at San Francisco, San Francisco, 1992\u20131999."},{"key":"9040_CR16","first-page":"1134","volume":"21","author":"G. Mannens","year":"1993","unstructured":"Mannens G., Huang M.L., Meuldermans W., Hendrickx J., Woestenborghs R., Heykants J. (1993) Absorption, metabolism, and excretion of risperidone in humans. Drug Metab. Dispos. 21:1134\u20131141","journal-title":"Drug Metab. Dispos."},{"key":"9040_CR17","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/sj.mp.4001494","volume":"9","author":"J. Kirchheiner","year":"2004","unstructured":"Kirchheiner J., Nickchen K., Bauer M., Wong M.L., Licinio J., Roots I., Brockmoller J. (2004) Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response. Mol. Psychiatry 9:442\u2013473","journal-title":"Mol. Psychiatry"},{"key":"9040_CR18","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/BF01060893","volume":"9","author":"L.B. Sheiner","year":"1981","unstructured":"Sheiner L.B., Beal S.L. (1981) Some suggestions for measuring predictive performance. J. Pharmacokinet. Biopharm. 9:503\u2013512","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"9040_CR19","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.clpt.2005.07.007","volume":"78","author":"S.M. Jung","year":"2005","unstructured":"Jung S.M., Kim K.-A., Cho H.-K., Jung I.G., Park P.-W., Byun W.T., Park J.-Y. (2005) Cytochrome P450 3A inhibitor itraconazole affects plasma concentrations of risperidone and 9-hydroxyrisperidone in schizophrenic patients. Clin. Pharmacol. Ther. 78:520\u2013528","journal-title":"Clin. Pharmacol. Ther."},{"key":"9040_CR20","volume-title":"SI Units in Medicine","author":"H. Lippert","year":"1978","unstructured":"Lippert H., Lehman H.P. (1978) SI Units in Medicine. Urban & Schwarzenberg, Baltimore-Munich"}],"container-title":["Journal of Pharmacokinetics and Pharmacodynamics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10928-006-9040-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10928-006-9040-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10928-006-9040-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T08:56:40Z","timestamp":1559465800000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10928-006-9040-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11,29]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,3,30]]}},"alternative-id":["9040"],"URL":"https:\/\/doi.org\/10.1007\/s10928-006-9040-2","relation":{},"ISSN":["1567-567X","1573-8744"],"issn-type":[{"value":"1567-567X","type":"print"},{"value":"1573-8744","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11,29]]}}}